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ABSTRACT Formation of new blood vessels in the
adult animal (i.e., angiogenesis) is an important event
for tissue repair and for tumor growth and metastasis.
Angiogenesis involves the migration and proliferation
of endothelial cells. We have investigated the role of
the growth suppressor p27Kip1 (p27) on endothelial cell
function in vitro and angiogenesis in vivo. We have
generated Ad-TetON, a replication-deficient adenovi-
rus that constitutively expresses the reverse tet-respon-
sive transcriptional activator, and Ad-TRE-p27, which
drives expression of p27 under the control of the tet
response element. Western blot analysis demonstrated
doxycycline-dependent overexpression of p27 in hu-
man umbilical vein endothelial cells (HUVECs) coin-
fected with Ad-TetON and Ad-TRE-p27, which resulted
in a marked inhibition of DNA replication and cell
migration in vitro. Inducible overexpression of p27 in
cultured HUVECs inhibited the formation of tubelike
structures and, when applied in a murine model of hind
limb ischemia, reduced hind limb blood flow recovery
and capillary density. These findings thus underscore a
novel role of p27 in regulating endothelial cell migra-
tion in vitro and angiogenesis in vivo, suggesting a novel
anti-angiogenic therapy based on inducible p27 overex-
pression.—Goukassian, D., Dı´ez-Juan, A., Asahara, T.,
Schratzberger, P., Silver, M., Murayama, T., Isner,
J. M., Andre´s, V. Overexpression of p27Kip1 by doxycy-
cline-regulated adenoviral vectors inhibits endothelial
cell proliferation and migration and impairs angiogen-
esis. FASEB J. 15, 1877–1885 (2001)
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The development of blood vessels is an important
event for embryonic organogenesis and tissue repair
during postnatal development (i.e., collateral vessel
development after a heart attack) (1). Similarly, the
requirement for a tumor to elaborate a vascular infra-
structure in order to grow and metastasize is well
documented (2, 3). Therefore, a better understanding
of the molecular mechanisms that control blood vessel
formation is important for the development of novel
therapies to augment or inhibit postnatal angiogenesis.
Angiogenesis involves the remodeling of the sur-
rounding extracellular matrix and the migration of
endothelial cells along a chemotactic gradient. More-
over, endothelial cells must leave their normal quies-
cent state and reenter the cell cycle during angiogene-
sis. Progression through the mammalian cell cycle
requires the activation of cyclin-dependent kinases
(CDKs) through their association with regulatory sub-
units called cyclins (4, 5). Different CDK/cyclin ho-
loenzymes are orderly activated at specific phases of the
cell cycle. Active CDK/cyclin complexes phosphorylate
the retinoblastoma gene product (pRb) and the related
pocket proteins p107 and p130 from mid-G1 to mitosis,
which in turn regulate the activity of members of the
E2F family of transcription factors (6, 7).
CDK activity is negatively regulated by specific cell
cycle regulatory proteins, termed CDK inhibitors
(CKIs), which associate with and inhibit the activity of
CDKs (4, 8). CKIs of the CIP/KIP family (p21, p27, and
p57) bind to and inactivate both the cyclin D-CDK4 and
cyclin E-CDK2 complexes, whereas members of the
INK4 family (p15, p16, p18, p19) are specific for CDK4-
and CDK6-containing holoenzymes. We and others
have suggested that up-regulation of p27 may limit the
growth of vascular smooth muscle cells (VSMCs) at late
time points after balloon angioplasty (9, 10). Consistent
with this possibility, overexpression of p27 efficiently
blocked mitogen- and c-fos-dependent induction of
cyclin A promoter activity in cultured VSMCs (9, 11),
and adenovirus-mediated overexpression of p27 atten-
uated neointimal thickening in balloon-injured arteries
(9, 12). In contrast, recent studies using p27 knockout
mice have demonstrated that the loss of p27 results in
prolonged proliferation of cardiac myocytes (13) and
enhanced atherosclerosis in hypercholesterolemic apo-
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lipoprotein E-deficient mice (14). p27 has also been
implicated in the regulation of cardiomyocyte hyper-
trophy (13) and angiotensin II-stimulated VSMC hyper-
trophy (15, 16).
The studies cited above identify p27 as an important
regulator of the phenotypic response of cardiac and
vascular myocytes to hyperplastic and hypertrophic
stimuli in vitro and in vivo. It has also been suggested
that alterations in p27 expression regulate the prolifer-
ation of cultured human umbilical vein endothelial
cells (HUVECs) and bovine aorta endothelial cells
during the transition from contact inhibition to the
proliferative state (17). However, little is known about
the role of p27 on endothelial cell migration and
angiogenesis. In the present study, we describe the
generation of an adenoviral system that allows doxycy-
cline-dependent overexpression of p27. Using this in-
ducible system, we investigated the effect of forced
overexpression of p27 on proliferation and migration
of HUVECs in vitro and on angiogenesis in a murine
model of surgically induced hind limb ischemia.
MATERIALS AND METHODS
Generation of adenoviral vectors
Replication-defective recombinant adenoviral constructs were
produced according to standard techniques (18). pACCMV-
TetON was generated by subcloning into the multiple cloning
site of pACCMVpLpA (19) an EcoRI/BamHI restriction frag-
ment isolated from pTetON (Clontech, Palo Alto, CA) that
contained the rtTA cDNA downstream from the CMV promoter.
To generate pDE1Sp1A-TRE-p27, a XhoI/HindIII p27 expres-
sion cassette was subcloned into pDE1Sp1A (Microbix Biosys-
tems, Ontario, Canada) digested with XhoI and HindIII. The
;1.5 kb p27 expression cassette contained a FLAG epitope-
tagged human p27 cDNA downstream from the TRE and CMV
minimal promoter. Recombinant adenovirus Ad-TetON and
Ad-TRE-p27 were generated by homologous recombination in
human embryo kidney 293 cells (20) cotransfected with pJM17
(21) and pACCMV-TetON or pDE1Sp1A-TRE-p27, respectively.
Viral stock titers were determined by plaque assay. For the hind
limb ischemia studies (see below), viruses were purified by CsCl
density gradient centrifugation.
In vitro assays with adenovirus
HUVECs were isolated from human umbilical cords as de-
scribed previously (22). Cells were grown onto 1.5% gelatin-
coated plates (Sigma, St. Louis, MO) in medium M199
supplemented with 20% fetal bovine serum (FBS) (both from
BioWhittaker, Walkersville, MD), 0.4% bovine brain extract
(Clonetics, San Diego, CA), 0.5% penicillin/streptomycin,
and 0.5% Fungizone. HUVECs were used between passages 3
and 8. Cells were maintained at 37°C in a humidified atmo-
sphere of air with 5% CO2.
To assess the level of p27 overexpression using the adeno-
viral system, HUVECs were seeded in 60 mm culture dishes,
grown to ;80% confluency, and incubated for 24 h with
Ad-TetON and Ad-TRE-p27 with or without doxycycline (1
mg/ml, Sigma) in the culture medium. Preparation of whole
cell lysates and Western blot analysis was as described previ-
ously (9). Rabbit polyclonal anti-p27 antibodies (1/250, Ab-1,
Oncogen Research Products, Cambridge, MA) were used to
detect adenovirus-encoded p27, which displayed slower elec-
trophoretic mobility than endogenous p27 due to the pres-
ence of an amino-terminal FLAG tag. Recombinant p27
expression could not be detected using monoclonal anti-
FLAG antibody.
HUVECs for flow cytometry were seeded in 6-well dishes
and serum-starved in medium containing 2% FBS (without
bovine brain extract). After 2 days of serum starvation, 6 3
107 pfu of each Ad-TetON and Ad-TRE-p27 were added for an
additional 16 h with or without doxycycline. Infected cells
were washed twice with PBS, fed fresh medium containing
20% FBS with or without doxycycline, and harvested 12 h
later for flow cytometry as described previously (11).
To assess the effect of doxycycline on cell proliferation,
asynchronously growing HUVECs exposed to different con-
centrations of doxycycline were incubated for 5 h with
3H-thymidine (1 mCi/ml, Amersham, United Kingdom), after
which cells were washed with PBS and incubated for 1 h with
ice-cold 5% trichloroacetic acid. Labeled DNA was extracted
with 0.5N NaOH and counted in a scintillation counter
(Wallac, Turku, Finland).
Migration assays were performed using a 48-well chemo-
taxis chamber (Neuroprobe, Bethesda, MD). After exposing
HUVECs to Ad-TRE-p27 and Ad-TetON (multiplicity of infec-
tion of 30 and 15, respectively) for 16 h, cells were trypsinized
and resuspended at 3 3 105/ml in chemotaxis medium
(M199 supplemented with 0.5% bovine serum albumin)
before being placed in the upper wells of a chemotaxis
chamber. The lower wells contained either control medium
or PDGF-BB (10 ng/ml) (Sigma). Upper and lower wells were
separated by a 8 mm pore polyvinylpyrrolidone-free polycar-
bonate filter (Poretics, Livermore, CA) precoated with fi-
bronectin (20 mg/ml, Sigma). Chemotaxis chambers were
incubated for 4 h at 37°C in a humidified atmosphere of air
with 5% CO2. Thereafter, the filters were fixed and stained
with Diff Qick (DADE, Aguada, Puerto Rico). Cells that had
not migrated were removed from the upper surface. After air
drying, the coverslips were mounted onto glass slides and
migration was quantified by counting the migrated cells in 20
randomly selected high power fields (2003).
To assess the effect of doxycycline on cell migration, HUVECs
labeled with the fluorescent dye Calcein-AM were placed in
FALCON HTS FluoroBlock inserts (8.0 mm pore size, 23104
cells/insert) (Becton Dickinson, Bedford, MA) in serum-free
medium. To induce migration, the lower chamber contained
complete medium. When indicated, doxycycline (1 mg/ml) was
added to both chambers. Chemotaxis was assessed by detecting
the fluorescence of cells migrating to the lower chamber using
a Victor 4120 multilabel counter (Wallac).
To examine the formation of tubelike structures, HUVECs
were seeded on 4-well chamber slides (53104 cells/well)
coated with Matrigel (Collaborative Biomedical Products,
Bedford, MA) and incubated for 24 h in medium containing
5% FBS. Control cells were not infected with adenovirus.
When indicated, cells were coinfected with Ad-TetON
(7.53105 pfu) and Ad-TRE-p27 (1.53106 pfu) with (1 mg/
ml) or without doxycycline in the medium.
In vitro assays with retrovirus
Recombinant retrovirus were generated using the retroviral
vectors pBabePuro-p27wt and pBabePuro-p27ck2 (gift of B.
Amati), which encode for wild-type p27 and a mutated p27
protein that is unable to interact with CDKs and cyclins (23),
respectively. Infection of asynchronously growing HUVECs was
performed as suggested by the supplier of the PT67 packaging
cells (Clontech). Uninfected HUVECs were used for control.
Cells were trypsinized, counted with an hemocytometer, and
plated on 12-well culture dishes at a density of 3 3 103 cells/well.
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Quantification of 3H-thymidine incorporation into DNA and
p27 Western blot analysis were performed as indicated above for
the studies with adenoviral vectors.
Hind limb ischemia studies
Unilateral hind limb ischemia in male C57/BL6J mice was
produced by occlusion of the femoral artery as described
previously (24). One week before surgery, mice were ran-
domly divided into 2 doxycycline and 1 doxycycline group
(at 1 mg/ml, in drinking water containing 2.5% sucrose).
Immediately after surgery, animals received in the left hind
limb an i.m. injection consisting of 60 ml of each Ad-TetON
(13108 pfu/ml) and Ad-TRE-p27 (13109 pfu/ml). Western
blot analysis was performed to assess the expression of
endogenous and adenovirally encoded p27 in cell extracts
prepared from ischemic muscle specimens pooled from three
mice retrieved 3 and 28 days after surgery. Serial assessment
of hind limb blood flow was performed using a PIM 2.0 laser
Doppler perfusion imager (Lisca, Mahwah, NJ) as described
(24, 25). Calculated perfusion was expressed as a ratio of left
(ischemic) to right (control) limb.
To determine capillary density, whole nonischemic and
ischemic limbs of two mice from each group were immedi-
ately fixed in methanol overnight. Histological sections (5 mm
thick) were prepared from paraffin-embedded tissue samples.
Endothelial cells were identified by histochemical staining
with biotinylated Griffin Simpliciforia lectin I isolectin B4
(Vector, Burlingame, CA), followed by peroxidase-conju-
gated ultrastreptavidin (Signet, Dedham, MA) and DAB sub-
strate (Vector). Sections were counterstained with Gill’s he-
matoxylin solution (Sigma). Six microscopic fields containing
cross sections of muscle fibers were randomly selected for
each animal (at a magnification of 663). Areas of 0.06 mm2
were photographed and printed on high quality photo-
graphic paper. Capillaries were identified as structures with
positive staining for isolectin B4 and appropriate morphol-
ogy. Neither vessel lumen nor red blood cells were used to
define a microvessel. The number of capillaries per muscle
fiber was counted in each photograph, and the counts of the
six chosen areas were averaged for each mouse. To eliminate
interobserver variations, a single investigator, who was
blinded to the treatment regimens, performed all counts.
RESULTS
Overexpression of p27 by a doxycycline-dependent
adenovirus-mediated system
Figure 1A schematizes the adenoviral system generated
to achieve inducible p27 expression. Ad-TetON directs
expression of the rtTA regulatory protein from the
CMV promoter. rtTA is a fusion of amino acids 1–207 of
the tet repressor (rTetR) and the carboxyl-terminal
activation domain (130 amino acids) of the VP16
protein of herpes simplex virus. A second adenoviral
vector, Ad-TRE-p27, directs expression of human p27
from the tet response element (TRE) and a minimal
CMV promoter (PminCMV). Under basal conditions,
transcription from Ad-TRE-p27 is minimal because
rtTA is in its inactive conformation. Inducible transcrip-
tion of the p27 cDNA is achieved via activation of
rTetR-VP16 by exposure to tetracycline or its derivative
doxycycline. We tested this system by Western blot
analysis of control and infected HUVECs (Fig. 1B).
Whereas endogenous p27 was detected at similar levels
in all conditions tested, adenovirally encoded p27 was
Figure 1. Doxycycline-dependent adenovirus-mediated overexpression of p27 in HUVECs. A) Schematic showing the adenoviral
system used to achieve doxycycline-dependent overexpression of p27. Addition of doxycycline activates DNA binding activity of the
fusion protein rTetR/VP16 encoded by Ad-TetON. ‘Active’ rTetR/VP16 turns on transcription of the p27 cDNA encoded by
Ad-TRE-p27 (see text for details). B) Western blot analysis using anti-p27 antibody and 50 mg of protein from whole cell extracts of
HUVECs coinfected with the indicated amounts of Ad-TetON and Ad-TRE-p27, with (1) or without (2) doxycycline in the culture
medium (at 1 mg/ml). The first lane corresponds to uninfected cells. The position of molecular weight markers is shown in the right.
Arrowheads on the left indicate the position of adenovirally encoded p27 (exo) and endogenous p27 (endo).
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detected only in cells coinfected with Ad-TetON and
Ad-TRE-p27 when doxycycline was added to the culture
medium. Moreover, the level of ectopically expressed
p27 increased gradually as the amount of Ad-TRE-p27
augmented from 1.5 3 105 to 4.5 3 106 pfu.
Serum-inducible proliferation of HUVECs is inhibited
by overexpression of p27
To test this system functionally, we examined the cell
cycle kinetics of HUVECs by flow cytometry (Fig. 2A).
In the absence of doxycycline, cultures coinfected with
Ad-TetON and Ad-TRE-p27 entered the cell cycle after
serum restimulation when compared with starvation-
synchronized HUVECs, as indicated by a significant
reduction in the proportion of cells in G0/G1 and
increased S-phase entry. In marked contrast, infected
cells exposed to doxycycline at 1 mg/ml failed to
progress through the cell cycle despite serum refeed-
ing. Control experiments showed that the addition of
doxycycline up to 100 mg/ml fails to inhibit de novo
DNA synthesis in serum-stimulated cultures of HUVECs
(Fig. 2B). These results demonstrate that doxycycline-
dependent overexpression of p27 can block cell cycle
progression of serum-stimulated HUVECs.
Additional control experiments were performed to
assess whether the inhibitory effect of ectopically ex-
pressed p27 might be due to nonspecific interference
with basic cellular functions resulting from massive
overexpression. Cultures of asynchronously growing
HUVECs were infected with retroviral vectors encoding
for wild-type p27 (p27wt) or a double mutant that had
lost the ability to form stable complexes with cyclins
and CDKs (p27ck2) and fails to inhibit CDK2 activity
(23). Consistent with our data from adenoviral vectors
(Fig. 2A), retrovirus-mediated overexpression of p27wt
greatly inhibited DNA synthesis compared with unin-
fected cells (Fig. 3A). In marked contrast, retrovirally
Figure 2. Doxycycline-dependent adenovirus-mediated over-
expression of p27 inhibits proliferation of HUVECs. A) Star-
vation-synchronized HUVECs were incubated for 16 h with
6 3 107 pfu of each Ad-TetON and Ad-TRE-p27 with (1
mg/ml) or without doxycycline, after which cultures were fed
fresh medium containing 20% FBS with or without doxycy-
cline and harvested 12 h later for flow cytometric analysis.
First bar: serum-starved cells. Data represent the mean of n 5
3 experiments 6 se. Differences were evaluated by ANOVA
and Fisher’s PLSD post hoc test. Comparisons between se-
rum-restimulated cells: *P , 0.001; **P , 0.0001. Compari-
sons between serum-starved and serum-restimulated cells:
†P , 0.005; ††P , 0.0001. B) Uninfected HUVECs were
maintained in the presence of 20% FBS and the indicated
concentrations of doxycycline. [3H]-thymidine was added
during the last 5 h; incorporation of radioactivity into DNA
was determined in triplicate samples. ANOVA and Fisher’s
PLSD post hoc test revealed no statistically significant differ-
ences among groups (P.0.05).
Figure 3. Overexpression of an inactivated mutant of p27 does not inhibit proliferation of HUVECs. Asynchronously growing
HUVECs were infected with retroviral vectors encoding for wild-type p27 (p27wt) or a mutated version that abrogates its
interaction with CDKs and cyclins (p27ck2). Uninfected HUVECs were used for control. A) Cells were incubated with
3H-thymidine to assess the effect of p27wt and p27ck2 overexpression on DNA synthesis. Results are expressed relative to control
(51) and represent the mean 6 se of the indicated number of assays. Differences were evaluated by ANOVA and Fisher’s PLSD
post hoc test. Comparisons vs. control: *P , 0.001; **P , 0.0001. Comparisons vs. p27ck2: †P , 0.0001. B) Western blot analysis
using anti-p27 and anti-tubulin antibodies. Note that infected cells overexpress recombinant p27 compared with the level of
endogenous p27 in control cultures.
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encoded p27ck2 slightly enhanced DNA synthesis.
These differences occurred despite the similar level of
overexpression of p27wt and p27ck2 (Fig. 3B).
Migration of HUVECs and tubulogenesis is inhibited
by overexpression of p27
We next used two well-established assays to assess the
potential regulatory role of p27 on cell motility. First,
the effect of p27 overexpression on cell migration was
tested in a modified Boyden chamber (Fig. 4A). Addi-
tion of PDGF-BB to HUVECs coinfected with Ad-
TetON and Ad-TRE-p27 and maintained in the absence
of doxycycline significantly increased the number of
migrated cells over basal migration in unstimulated
cells. However, addition of doxycycline at 1 mg/ml
significantly reduced both basal and PDGF-BB-induced
migration of infected cells. Control experiments dem-
onstrated that doxycycline by itself, at the concentra-
tion used in these studies, does not inhibit migration of
HUVECs (Fig. 4B).
Endothelial cells plated on a Matrigel substrate at-
tach and migrate to form tubelike structures (26, 27).
Therefore, we also investigated the effect of p27 on
HUVEC motility in this in vitro model system. Cultures
of HUVECs were uninfected or coinfected with Ad-
TetON and Ad-TRE-p27 and seeded on Matrigel-coated
culture dishes. As shown in Fig. 5, addition of doxycy-
cline to infected HUVECs reduced tubulogenesis rela-
tive to both uninfected cultures and infected cells in
the absence of doxycycline.
Overexpression of p27 inhibited blood flow recovery
and reduced capillary density in ischemic limbs
The in vitro results presented thus far demonstrate that
ectopic overexpression of p27 can inhibit endothelial
cell functions essential for angiogenesis (i.e., cell pro-
liferation and migration). To examine whether induc-
Figure 4. Doxycycline-dependent adenovirus-mediated overexpression of p27 inhibits migration of HUVECs. A) After exposing
HUVECs to Ad-TRE-p27 and Ad-TetON for 16 h, cells were trypsinized and placed in the upper wells of a modified Boyden
chamber. The lower wells contained either control medium (first bar) or PDGF-BB (10 ng/ml). When indicated, doxycycline
was added at 1 mg/ml. Migration was quantified by counting the migrated cells in 20 randomly selected high power fields (HPF).
Data represent the mean of n 5 8 assays 6 se. Differences were evaluated by ANOVA and Fisher’s PLSD post hoc test.
Comparisons between unstimulated and PDGF-BB-stimulated cells: *P , 0.0001. Comparisons between PDGF-BB-stimulated
cells: †P , 0.0001. B) HUVECs labeled with the fluorescent dye Calcein-AM were placed in FALCON HTS FluoroBlock inserts
in serum-free medium with (1 mg/ml) or without doxycycline. Chemotaxis was assessed by detecting the fluorescence of cells
migrating to the lower chamber (which contained complete medium). Data represents the mean 6 se of 2 assays. For each
condition, results are expressed relative to baseline fluorescence at 0 h (51). Two-tail unpaired Student’s t test at each time
point only revealed increased migration in the doxycycline group at 1 h (*P,0.05).
Figure 5. Doxycycline-dependent overexpression of p27 in-
hibits HUVEC tubulogenesis. HUVECs were seeded at 5 3
104 cells/well on Matrigel-coated 4-well chamber slides and
incubated for 24 h in medium containing 5% FBS. Control
cells were not infected with adenovirus. When indicated, cells
were coinfected with Ad-TetON (7.53105 pfu) and Ad-TRE-
p27 (1.53106 pfu) with or without doxycycline in the me-
dium. All assays were done in quadruplicate. Two represen-
tative photomicrographs of each condition are shown.
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ible overexpression of p27 can indeed impair de novo
blood vessel formation, we performed gene transfer
experiments in a murine hind limb model of acute
ischemia. Immediately after surgery, all mice received
Ad-TetON and Ad-TRE-p27 via an i.m. injection in the
injured leg. Western blot analysis demonstrated doxy-
cycline-dependent overexpression of adenovirally en-
coded p27 in ischemic muscle specimens retrieved 3
and 28 days after surgery (Fig. 6A). Angiogenesis was
quantified by laser Doppler perfusion imaging and
measurement of capillary density. As revealed by Dopp-
ler analysis of Fig. 6B, hind limb blood flow in the 2
doxycycline group of adenovirally infected mice was
precipitously reduced after surgery (day 0), increased
steadily between postsurgery days 7, 14, and 21, and
remained elevated by day 28. A similar precipitous
reduction in hind limb blood flow occurred in mice
receiving adenovirus and doxycycline; however, in con-
trast to 2 doxycycline group, flow recovery was negli-
gible up to postoperative day 28 (Fig. 6B). This corre-
sponded to a significant reduction in capillary density
in the ischemic hind limb at day 35 after surgery in
mice receiving adenovirus and doxycycline (Fig. 6C).
Control experiments with uninfected animals demon-
strated that doxycycline by itself, at the concentration
used in these studies, does not inhibit blood flow
recovery (Fig. 7). Collectively, these results demon-
strate that doxycycline-dependent overexpression of
p27 can impair blood flow recovery and reduce capil-
lary density in a murine model of hind limb ischemia.
DISCUSSION
Four major conclusions arise as a result of our studies:
1) an adenoviral system has been developed that allows
doxycycline-dependent overexpression of p27 in cul-
tured cells and in experimental animals; 2) inducible
overexpression of p27 in HUVECs blocked DNA repli-
cation; 3) inducible overexpression of p27 in HUVECs
inhibited cellular migration and tubulogenesis in vitro,
and 4) inducible overexpression of p27 impaired angio-
genesis in a murine model of hind limb ischemia. In
addition to the expected inhibitory effect of p27 on cell
growth, these findings underscore a novel role for p27
in the regulation of endothelial cell migration in vitro
and on angiogenesis in vivo. Our in vitro results extend
previous studies reporting the ability of the CKIs p16
and p21 to inhibit cell spreading and migration when
overexpressed in a variety of cell types, including
HUVECs, VSMCs, and CS-1 b3 melanoma cells (28, 29).
Together, these studies suggest that members of the
Figure 7. Doxycycline treatment does not affect blood flow
recovery after acute ischemia. Mice were treated as described
in Fig. 6, except that animals did not receive the injection of
adenovirus. Hind limb blood flow recovery was assessed by
Doppler analysis at different time points after surgery. Results
at each time point represent the mean 6 se of 10 mice.
Differences were evaluated by ANOVA and Fisher’s PLSD
post hoc test. Analysis at each time point revealed no differ-
ences between 2 doxycycline and 1 doxycycline groups
(P .0.05). Comparisons between day 0 and all postsurgery
time points disclosed P , 0.0001 in both groups. Analysis of
all postsurgery time points vs. ‘before surgery’ disclosed P ,
0.0001, except day 21 in the 1 doxycycline group (P,0.005).
Figure 6. Doxycycline-dependent overexpression of p27 im-
pairs blood flow recovery and reduces capillary density after
acute ischemia. Mice were randomly divided into two groups:
2 doxycycline and 1 doxycycline 1 wk before inducing
ischemia in the left hind limb. All mice received in the
ischemic leg an i.m. injection containing Ad-TetON (63106
pfu) and Ad-TRE-p27 (63107 pfu) immediately after surgery.
A) Western blot analysis was performed to assess doxycycline-
dependent overexpression of adenovirally encoded p27 [p27
(exo)] in cell extracts from ischemic muscle specimens
retrieved 3 and 28 days after surgery. p27 (endo): endoge-
nous p27. B) Hind limb blood flow recovery was assessed by
Doppler analysis at different time points after surgery. Results
at each time point represent the mean 6 se of 8–10 mice.
Differences were evaluated by ANOVA and Fisher’s PLSD
post hoc test. Comparisons between groups at each time
point: *P , 0.025; **P , 0.004; ***P , 0.0001. Comparisons
postsurgery vs. day 0 (within each group): †P , 0.00025;
††P , 0.0001. Analysis of all postsurgery time points vs.
‘before surgery’ disclosed P , 0.0001. C) Relative capillary
density at postoperative day 35 in nonischemic (2surgery)
and ischemic (1surgery) hind limbs is expressed as number
of capillaries per muscle fiber. Results represent the mean 6
se of 12 randomly chosen areas of 0.06 mm2 of muscle fiber
from 2 mice. See Material and Methods for details.
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CKI family of growth suppressors are important regu-
lators of cell migration.
Consistent with previous in vitro studies (30), incu-
bation with doxycycline up to 100 mM did not signifi-
cantly inhibit the growth of HUVECs. Similarly, we have
shown that doxycycline at 1 mM did not inhibit the
migration of HUVECs nor did concentrations up to
10.4 mM impair the formation of tubelike structures
(30). It is also noteworthy that tetracycline analogs,
including doxycycline, have been shown to inhibit the
activity of several metalloproteinases in vitro and in vivo
(31–36). This inhibitory effect of doxycycline could
impair matrix degradation and therefore limit angio-
genesis in the murine hind limb model of acute isch-
emia. However, at the concentrations used in our
studies, treatment with doxycycline did not affect blood
flow recovery.
Cellular migration and proliferation are important
events during angiogenesis (1, 2). Thus, it is reasonable
to presume that the ability of p27 to inhibit cellular
growth and migration contributes to the anti-angio-
genic effect of p27 overexpression reported here. Of
further interest is the wealth of evidence indicating that
angiogenesis is required for tumor growth and metas-
tasis (2, 3). Indeed, several anti-angiogenic therapies
have proved efficient at inhibiting tumor progression in
animal models of cancer (3, 37–39). Moreover, it is
appropriate to consider previous studies showing that
adenovirus-mediated overexpression of the growth sup-
pressors p53 (40) and p16 (41) inhibited angiogenesis
induced in vivo by human cancer cells. Schreiber et al.
(42) compared the efficacy of different CKIs at inhib-
iting tumor formation in a polyomavirus middle T
antigen model of murine breast carcinoma. These
authors demonstrated that adenovirus-mediated over-
expression of p16, p18, p21, and p27 results in a
significant delay in tumor progression, varying from 5
wk for p21 to more than 25 wk for p27. Similarly, in
vitro experiments with human breast cancer cells MDA-
MB-231 and MCF-7 infected with recombinant adeno-
virus expressing p27 and p21 showed a markedly more
(up to 56-fold) potent growth inhibitory effect of p27
(43). Thus, p27 may be a better candidate than other
CKIs for gene therapy of tumors. p27-deficient mice are
predisposed to tumorigenesis in multiple tissues when
challenged with g irradiation or a chemical carcinogen;
p27 heterozygous mice were also more susceptible than
wild-type animals, but at intermediate rates (44). The
sensitivity to p27 dosage suggests that reduced p27
expression might be a common event during tumor
growth. Indeed, low expression of p27 has frequently
been found in several human cancers, and this is highly
predictive of tumor progression and patient mortality
(45–52). Conversely, acquired expression of p27 might
be a favorable independent prognostic indicator in
patients with hepatocellular carcinoma (53). It is also
noteworthy that p27 expression appears to correlate
inversely with vascular cell proliferation in human
atherosclerotic tissue (10, 54) and that p27 inactivation
accelerates the development of atherosclerotic lesions
in hypercholesterolemic apolipoprotein E-deficient
mice (14). Collectively, these studies suggest that resto-
ration of p27 function might be effective for the
treatment of cancer and atherosclerosis.
Although available scientific evidence supports the
feasibility of human gene therapy, major benefit is
expected from the perfection of current vectors and/or
the development of new gene delivery strategies (55).
As indicated by numerous animal studies, a major
limitation of current adenoviral vectors is the substan-
tial drop in gene expression normally seen shortly after
delivery (typically 1–2 wk). Our study shows sustained
doxycycline-dependent overexpression of adenovirally
encoded p27 up to 28 days postinjection into the hind
limb. Similarly, Harding and co-workers reported per-
sistent doxycycline-regulated adenovirus-mediated gene
expression up to 3 months after local transfer into
neuronal cells in vivo (56). Thus, the long-term expres-
sion achieved with doxycycline-regulatable adenoviral
system may be considered for future experimental and
clinical applications. This inducible system may provide
additional advantages over conventional gene therapy
strategies. For example, an inescapable concern when
overexpressing a therapeutic gene is the possibility of
undesirable systemic effects, especially when a poten-
tially harmful gene is being delivered. Thus, using an
inducible strategy to maintain gene expression for a
defined length of time seems sure to mitigate inherent
potential risks, particularly in diseases for which a
relatively short period of treatment might be effective
(i.e., postangioplasty restenosis). The combined use of
constitutive and inducible expression systems may be
desirable in cases where the susceptibility of target cells
to a given therapeutic agent depends on exposure to a
‘priming’ agent. Last, future anti-cancer therapies that
rely on the combination of gene therapy and conven-
tional strategies (i.e., chemotherapy, radiotherapy, im-
munotherapy) may also benefit from inducible gene
expression.
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